Class information for:
Level 1: STEM CELL TOURISM//PROGRAM STEM CELLS SOC//UK STEM CELL BANK

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
17577 529 34.6 46%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1294 8163 FOOD AND DRUG LAW JOURNAL//GENERIC SUBSTITUTION//DIRECT TO CONSUMER ADVERTISING

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 STEM CELL TOURISM Author keyword 19 74% 3% 14
2 PROGRAM STEM CELLS SOC Address 7 64% 1% 7
3 UK STEM CELL BANK Author keyword 6 80% 1% 4
4 ARTS C209 Address 6 100% 1% 4
5 STEM CELL SCIENCE Author keyword 4 67% 1% 4
6 STEM CELL RESEARCH Author keyword 4 15% 5% 24
7 NEW GENETICS AND SOCIETY Journal 4 10% 6% 34
8 GLOBAL BIOPOLIT GRP Address 3 37% 1% 7
9 ADVANCED THERAPY MEDICINAL PRODUCTS Author keyword 3 35% 1% 7
10 BIONETWORKING Address 3 60% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 STEM CELL TOURISM 19 74% 3% 14 Search STEM+CELL+TOURISM Search STEM+CELL+TOURISM
2 UK STEM CELL BANK 6 80% 1% 4 Search UK+STEM+CELL+BANK Search UK+STEM+CELL+BANK
3 STEM CELL SCIENCE 4 67% 1% 4 Search STEM+CELL+SCIENCE Search STEM+CELL+SCIENCE
4 STEM CELL RESEARCH 4 15% 5% 24 Search STEM+CELL+RESEARCH Search STEM+CELL+RESEARCH
5 ADVANCED THERAPY MEDICINAL PRODUCTS 3 35% 1% 7 Search ADVANCED+THERAPY+MEDICINAL+PRODUCTS Search ADVANCED+THERAPY+MEDICINAL+PRODUCTS
6 ATMP 2 26% 2% 8 Search ATMP Search ATMP
7 BIOMEDICAL RESEARCH POLICY 2 67% 0% 2 Search BIOMEDICAL+RESEARCH+POLICY Search BIOMEDICAL+RESEARCH+POLICY
8 SOCIOTECHNICAL IMAGINARY 2 67% 0% 2 Search SOCIOTECHNICAL+IMAGINARY Search SOCIOTECHNICAL+IMAGINARY
9 STEM CELL TREATMENTS 2 67% 0% 2 Search STEM+CELL+TREATMENTS Search STEM+CELL+TREATMENTS
10 TISSUE ENGINEERED PRODUCT 2 67% 0% 2 Search TISSUE+ENGINEERED+PRODUCT Search TISSUE+ENGINEERED+PRODUCT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 THERAPY MEDICINAL PRODUCTS 6 80% 1% 4
2 PG 335 5 23% 4% 19
3 MEDICINE PRODUCT COMMERCIALIZATION 3 100% 1% 3
4 TISSUE ENGINEERED PRODUCTS 3 100% 1% 3
5 RETRACTED SEE 2 18% 2% 11
6 JAN 20 2006 2 15% 2% 11
7 HUMAN IMPLANT TECHNOLOGIES 1 50% 0% 2
8 INNOVATIVE THERAPY 1 100% 0% 2
9 STEM CELL SCIENCE 1 40% 0% 2
10 AUTOLOGOUS CULTURED EPITHELIUM 1 50% 0% 1

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEW GENETICS AND SOCIETY 4 10% 6% 34

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
From bench to FDA to bedside: US regulatory trends for new stem cell therapies 2015 2 6 33%
A question of ethics: Selling autologous stem cell therapies flaunts professional standards 2014 6 14 86%
The translation of cell-based therapies: clinical landscape and manufacturing challenges 2015 2 52 15%
European Regulatory Tools for Advanced Therapy Medicinal Products 2013 2 3 100%
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry 2013 17 5 20%
Current regulatory issues in cell and tissue therapy 2003 28 8 50%
Raising the standard: changes to the Australian Code of Good Manufacturing Practice ( cGMP) for Human Blood and Blood Components, Human Tissues and Human Cellular Therapy Products 2014 0 1 100%
Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research 2014 5 15 40%
Achieving reimbursement for regenerative medicine products in the USA 2010 7 7 57%
Commerical development of stem cell technology: lessons from the past, strategies for the future 2006 12 4 50%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PROGRAM STEM CELLS SOC 7 64% 1.3% 7
2 ARTS C209 6 100% 0.8% 4
3 GLOBAL BIOPOLIT GRP 3 37% 1.3% 7
4 BIONETWORKING 3 60% 0.6% 3
5 EPSRC INNOVAT MFG REGENERAT MED 2 67% 0.4% 2
6 TUMCELLS INTERDISCIPLINARY CELLULAR THER IES 2 67% 0.4% 2
7 BIOMED SOC 2 19% 1.3% 7
8 DANKOOK DISPUTE OLUT 1 100% 0.4% 2
9 SATSU 1 22% 0.9% 5
10 PHYS HLTH PROGRAM 1 40% 0.4% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000131110 PROGRAM LIFE SCI ETH POLICY//MCLAUGHLIN ROTMAN GLOBAL HLTH//ESRC INNOGEN
2 0.0000115585 MORAL STATUS//EMBRYO EXPERIMENTATION//MORAL ARROGANCE
3 0.0000111807 MEDICAL TOURISM//CROSS BORDER HEALTH CARE//MEDICAL TRAVEL
4 0.0000091073 NIDHAL GUESSOUM//LEIDEN RELIGIOUS STUDIES//ISLAM AND SCIENCE
5 0.0000090031 PUBLIC UNDERSTANDING OF SCIENCE//SCIENCE COMMUNICATION//PUBLIC ENGAGEMENT
6 0.0000079293 HUMAN EMBRYONIC STEM CELLS//HUMAN EMBRYONIC STEM CELL//FEEDER FREE CULTURE
7 0.0000071466 CHIR NET//STUDIENZENTRUM DEUT GESELL CHIRURG//ORTHOPAEDICS AND TRAUMATOLOGY
8 0.0000070343 PARTHENOGENETIC EMBRYONIC STEM CELL//HEART DIS CARDIOTHORAC SURG//PARTHENOGENETIC STEM CELLS
9 0.0000065149 GENE PATENTS//INTELLECTUAL PROPERTY RIGHTS//EUROPEAN PATENT CONVENTION
10 0.0000063724 CYTOSKELETAL FORMATION//DENDRIMER IMMOBILIZED SURFACE//GLUCOSE DISPLAYING DENDRIMER SURFACE